A One Year, Open-Label Outpatient, Parallel Group Trial Assessing the Impact of the Availability of Inhaled Insulin (Exubera) on Glycemic Control in Patients With Type 2 Diabetes Mellitus Who Are Poorly Controlled on a Minimum of Two Oral Anti Diabetic Agents

Percent of patients achieving good control of fasting glucose and lipids

Rate of hypoglycemia

Changes in body weight

Patient satisfaction

Safety based on adverse events reported and laboratory tests

Estimated Enrollment:

1100

Study Start Date:

April 2005

Study Completion Date:

May 2007

Eligibility

Ages Eligible for Study:

35 Years to 80 Years (Adult, Senior)

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

No

Criteria

Inclusion Criteria:

Diabetes mellitus Type 2

Failing two or more oral anti-diabetic agents

Exclusion Criteria:

Asthma, COPD

Smoking

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00134147